The major histocompatibility complex (MHC) plays a key role in regulating the immune response, but MHC molecules may also have a more generalized role in a variety of cellular functions. MHC molecules associate with cell surface molecules involved in cell growth and also share many physical characteristics with receptor molecules. It is thus likely that MHC molecules may have receptor functions as well. This proposal focuses on two additional functions of MHC molecules that we recently described: the regulation of the cytolytic activity of human natural killer (NK) cells, and a role in the activation and proliferation of human T and B lymphocytes and NK cells. The major goal of this project is to determine the mechanism by which MHC cell surface molecules affect both cytolytic activity and lymphocyte growth and activation. Monoclonal antibodies (mAbs) with specificity for HLA class I and class II molecules were generated which affect the lytic activity of a cloned line of human NK cells (NK 3.3). The HLA class I- specific mAb that augments lysis (mAb 131) has been characterized as a unique anti-HLA-A locus-specific mAb. In contrast, an anti-HLA-B locus-specific mAb (4E) inhibits killing, suggesting HLA class I-locus-specific effects on NK function. Similarly, the anti-HLA-A and anti-HLA-B locus-specific mAbs have differential effects on the activation of T and B lymphocytes by a variety of mitogens. Such functional differences in HLA-A and B locus-encoded gene products have not been previously described. These mAbs are thus valuable tools for understanding the role of MHC molecules in lymphocyte functions. The working hypothesis is: 1) MHC molecules associate with functionally important receptors in the membranes of NK cells, T cells and B cells, and 2) HLA-A locus and B locus gene products form different associations resulting in different functional effects of the antibodies directed against them. We will test this hypothesis by: 1) examining potential physical associations of MHC class I A and B locus-encoded molecules with other functionally important molecules on NK, T and B cells, 2) studying differential recycling and phosphorylation of MHC molecules in these cells, and 3) studying changes in early metabolic events and gene expression associated with activation or lytic activity in NK, T and B cells in the absence and presence of the anti-HLA and B locus-specific mAbs. These studies will provide further information on the role of the MHC in cellular functions, including growth, and provide greater insight into the mechanisms and regulation of lytic function and cellular proliferation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA037827-04
Application #
3175678
Study Section
Immunobiology Study Section (IMB)
Project Start
1984-07-01
Project End
1988-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Leiden, J M; Karpinski, B A; Gottschalk, L et al. (1989) Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression. J Immunol 142:2140-7
Mahle, N H; Radcliff, G; Sevilla, C L et al. (1989) Kinetics of cellular cytotoxicity mediated by a cloned human natural killer cell line. Immunobiology 179:230-43
Kornbluth, J; Hoover, R G (1988) Changes in gene expression associated with IFN-beta and IL-2-induced augmentation of human natural killer cell function. J Immunol 141:3234-40
Leiden, J M; Gottesdiener, K M; Quertermous, T et al. (1988) T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor alpha, beta, or gamma genes. Immunogenetics 27:231-8
Lefkowitz, M; Kornbluth, J; Tomaszewski, J E et al. (1988) Natural killer-cell activity in cyclosporine-treated renal allograft recipients. J Clin Immunol 8:121-7
Taylor, D S; Nowell, P C; Kornbluth, J (1987) Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes. J Immunol 139:1792-6
Hart, M K; Kornbluth, J; Main, E K et al. (1987) Lymphocyte function-associated antigen 1 (LFA-1) and natural killer (NK) cell activity: LFA-1 is not necessary for all killer: target cell interactions. Cell Immunol 109:306-17
Lefkowitz, M; Jorkasky, D; Kornbluth, J (1987) Increase in natural killer activity in cyclosporine-treated renal allograft recipients during rejection. Hum Immunol 19:139-49
Taylor, D S; Nowell, P C; Kornbluth, J (1986) Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation. Proc Natl Acad Sci U S A 83:4446-50
Spear, B T; Kornbluth, J; Strominger, J L et al. (1985) Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131. J Exp Med 162:1802-10